162 related articles for article (PubMed ID: 34948188)
21. Conformational multiplicity of bacterial ferric binding protein revealed by small angle x-ray scattering and molecular dynamics calculations.
Liu G; Ekmen E; Jalalypour F; Mertens HDT; Jeffries CM; Svergun D; Atilgan AR; Atilgan C; Sayers Z
J Chem Phys; 2023 Feb; 158(8):085101. PubMed ID: 36859088
[TBL] [Abstract][Full Text] [Related]
22. Binding to cellular receptors results in increased iron release from transferrin at mildly acidic pH.
Sipe DM; Murphy RF
J Biol Chem; 1991 May; 266(13):8002-7. PubMed ID: 2022630
[TBL] [Abstract][Full Text] [Related]
23. Interaction of imatinib mesylate with human serum transferrin: The comparative spectroscopic studies.
Śliwińska-Hill U
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():468-475. PubMed ID: 27718450
[TBL] [Abstract][Full Text] [Related]
24. Different segmental flexibility of human serum transferrin and lactoferrin.
Vígh R; Cser L; Kilár F; Simon I
Arch Biochem Biophys; 1989 Nov; 275(1):181-4. PubMed ID: 2817894
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure and iron-binding properties of the R210K mutant of the N-lobe of human lactoferrin: implications for iron release from transferrins.
Peterson NA; Anderson BF; Jameson GB; Tweedie JW; Baker EN
Biochemistry; 2000 Jun; 39(22):6625-33. PubMed ID: 10828980
[TBL] [Abstract][Full Text] [Related]
26. The molecular mechanism for receptor-stimulated iron release from the plasma iron transport protein transferrin.
Giannetti AM; Halbrooks PJ; Mason AB; Vogt TM; Enns CA; Björkman PJ
Structure; 2005 Nov; 13(11):1613-23. PubMed ID: 16271884
[TBL] [Abstract][Full Text] [Related]
27. A computational study of the open and closed forms of the N-lobe human serum transferrin apoprotein.
Rinaldo D; Field MJ
Biophys J; 2003 Dec; 85(6):3485-501. PubMed ID: 14645044
[TBL] [Abstract][Full Text] [Related]
28. Camel lactoferrin, a transferrin-cum-lactoferrin: crystal structure of camel apolactoferrin at 2.6 A resolution and structural basis of its dual role.
Khan JA; Kumar P; Paramasivam M; Yadav RS; Sahani MS; Sharma S; Srinivasan A; Singh TP
J Mol Biol; 2001 Jun; 309(3):751-61. PubMed ID: 11397094
[TBL] [Abstract][Full Text] [Related]
29. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
30. X-ray structures of transferrins and related proteins.
Mizutani K; Toyoda M; Mikami B
Biochim Biophys Acta; 2012 Mar; 1820(3):203-11. PubMed ID: 21855609
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional consequences of binding site mutations in transferrin: crystal structures of the Asp63Glu and Arg124Ala mutants of the N-lobe of human transferrin.
Baker HM; He QY; Briggs SK; Mason AB; Baker EN
Biochemistry; 2003 Jun; 42(23):7084-9. PubMed ID: 12795604
[TBL] [Abstract][Full Text] [Related]
32. Alternative structural state of transferrin. The crystallographic analysis of iron-loaded but domain-opened ovotransferrin N-lobe.
Mizutani K; Yamashita H; Kurokawa H; Mikami B; Hirose M
J Biol Chem; 1999 Apr; 274(15):10190-4. PubMed ID: 10187803
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of the ectodomain of human transferrin receptor.
Lawrence CM; Ray S; Babyonyshev M; Galluser R; Borhani DW; Harrison SC
Science; 1999 Oct; 286(5440):779-82. PubMed ID: 10531064
[TBL] [Abstract][Full Text] [Related]
34. The importance of protein-protein interactions on the pH-induced conformational changes of bovine serum albumin: a small-angle X-ray scattering study.
Barbosa LR; Ortore MG; Spinozzi F; Mariani P; Bernstorff S; Itri R
Biophys J; 2010 Jan; 98(1):147-57. PubMed ID: 20085727
[TBL] [Abstract][Full Text] [Related]
35. The solution configurations of inactive and activated DntR have implications for the sliding dimer mechanism of LysR transcription factors.
Lerche M; Dian C; Round A; Lönneborg R; Brzezinski P; Leonard GA
Sci Rep; 2016 Jan; 6():19988. PubMed ID: 26817994
[TBL] [Abstract][Full Text] [Related]
36. Predicting long term cooperativity and specific modulators of receptor interactions in human transferrin from dynamics within a single microstate.
Abdizadeh H; Atilgan C
Phys Chem Chem Phys; 2016 Mar; 18(11):7916-26. PubMed ID: 26955866
[TBL] [Abstract][Full Text] [Related]
37. Apolactoferrin structure demonstrates ligand-induced conformational change in transferrins.
Anderson BF; Baker HM; Norris GE; Rumball SV; Baker EN
Nature; 1990 Apr; 344(6268):784-7. PubMed ID: 2330032
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Transferrin in the Urine of Patients with Bladder Cancer Using Nanobodies.
Sachko AM; Goryainova OS; Ivanova TI; Nikolaeva IY; Tarnopolskaia ME; Bychkov AY; Gaas MY; Vorob'ev NV; Kaprin AD; Shegay PV; Tillib SV
Biochemistry (Mosc); 2023 Aug; 88(8):1105-1115. PubMed ID: 37758310
[TBL] [Abstract][Full Text] [Related]
39. An iron-dependent and transferrin-mediated cellular uptake pathway for plutonium.
Jensen MP; Gorman-Lewis D; Aryal B; Paunesku T; Vogt S; Rickert PG; Seifert S; Lai B; Woloschak GE; Soderholm L
Nat Chem Biol; 2011 Jun; 7(8):560-5. PubMed ID: 21706034
[TBL] [Abstract][Full Text] [Related]
40. Determining the glycation site specificity of human holo-transferrin.
Silva AMN; Coimbra JTS; Castro MM; Oliveira Â; Brás NF; Fernandes PA; Ramos MJ; Rangel M
J Inorg Biochem; 2018 Sep; 186():95-102. PubMed ID: 29860209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
